• Original article (Clinical research) • Previous Articles Next Articles
LUO Da-wei, ZHENG Zhi, LIU Kun, ZHU Bi-jun, XIA Xin, XU Xun, ZOU Hai-dong
Online:
Published:
Supported by:
Shanghai Key Laboratory for Ocular Fundus Disease Foundation, 07Z22911
Abstract:
Objective To investigate the serum transforming growth factor-β (TGF-β) levels in patients with diabetic retinopathy (DR). Methods Seventy-two patients with diabetes were selected, including 15 patients with proliferative diabetic retinopathy (PDR group), 32 patients with non-proliferative diabetic retinopathy (NPDR group) and 25 patients with non-diabetic retinopathy group (NDR group). Besides, 45 healthy people were served as normal control group. The serum TGF-β levels were detected by ELISA. Results Serum TGF-β levels in groups with diabetes were significantly higher than that in normal control group (P<0.01). Serum TGF-β level in PDR group was significantly higher than those in NPDR group and NDR group (P<0.05). Conclusion Serum TGF-β level is associated with the severity of diabetic retinopathy.
Key words: diabetic retinopathy, transforming growth factor-β, proliferative diabetic retinopathy
LUO Da-wei, ZHENG Zhi, LIU Kun, et al. Serum transforming growth factor-β levels in patients with diabetic retinopathy[J]. , doi: 10.3969/j.issn.1674-8115.2013.07.019.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2013.07.019
https://xuebao.shsmu.edu.cn/EN/Y2013/V33/I7/990